# Lot-to-lot Consistency Trial of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine

> **NCT01567865** · PHASE4 · COMPLETED · sponsor: **PATH** · enrollment: 818 (actual)

## Conditions studied

- Japanese Encephalitis

## Interventions

- **BIOLOGICAL:** Vaccine produced in existing facility
- **BIOLOGICAL:** Vaccine produced in new facility

## Key facts

- **NCT ID:** NCT01567865
- **Lead sponsor:** PATH
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 818 (ACTUAL)
- **Last updated:** 2018-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01567865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01567865, "Lot-to-lot Consistency Trial of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01567865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*